Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

XPREZA 100 INJECTION 100 MG/VIAL

Approval Number

SIN15118P

Drug Name

XPREZA 100 INJECTION 100 MG/VIAL

Product Name

XPREZA 100 INJECTION 100 MG/VIAL

Approval Date

November 23, 2016

Registrant

NATCO PHARMA ASIA PTE. LTD.

Licence Holder

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

Registrant

NATCO PHARMA ASIA PTE. LTD.

Licence Holder

NATCO PHARMA ASIA PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

L01BC07

ATC Item Name

azacitidine

Manufacturer Information

Pharmaceutical Manufacturer

NATCO PHARMA ASIA PTE. LTD.

Manufacturers

Natco Pharma Limited

Panacea Biotec Pharma Ltd.

Active Ingredients

Ingredient Name

Azacitidine

Strength

100mg

Drug MonographAzacitidine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

XPREZA 100 INJECTION 100 MG/VIAL - HSA Approval | MedPath